Ignite Planners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Ignite Planners's BMY Position: Q2 2026 in Review
Ignite Planners reduced its Bristol-Myers Squibb (BMY) stake by 1.2% in Q2 2026, selling an estimated $17K and leaving 24,414 shares worth $1.41M. The position accounts for 0.19% of the portfolio, ranked #129.
Ignite Planners first reported a position in BMY in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.49M in Q1 2026. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Ignite Planners held 24,414 shares of Bristol-Myers Squibb worth $1.41M as of Q2 2026.
- Ignite Planners sold 296 Bristol-Myers Squibb shares in Q2 2026, an estimated $17K.
- Bristol-Myers Squibb made up 0.19% of Ignite Planners's portfolio in Q2 2026, its #129 holding.
- Ignite Planners first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 14 quarters since.
- Ignite Planners's Bristol-Myers Squibb position peaked at $1.49M in Q1 2026.
- 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Ignite Planners's 13F filing for Q2 2026, filed 23 Jul 2026.